BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23522642)

  • 21. Hyperviscosity in plasma cell dyscrasias.
    Kwaan HC
    Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irreversible visual loss in Waldenström's macroglobulinaemia.
    Thomas EL; Olk RJ; Markman M; Braine H; Patz A
    Br J Ophthalmol; 1983 Feb; 67(2):102-6. PubMed ID: 6401430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Waldenström's macroglobulinemia as a diagnostic challenge: case report.
    Budimir I; Nikolić M; Pusić MS; Hrabar D; Ljubicić N; Duvnjak M; Supanc V; Nikolac I; Babić N; Sokcević M
    Acta Clin Croat; 2014 Mar; 53(1):94-7. PubMed ID: 24974671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic effects of plasmapheresis in Waldenström's disease].
    Moulinier J; Servantie X; Mesnier F
    J Med Bord; 1967 Sep; 144(9):1295-300. PubMed ID: 4988704
    [No Abstract]   [Full Text] [Related]  

  • 25. How we treat Waldenström's macroglobulinemia.
    Dimopoulos MA; Merlini G; Leblond V; Anagnostopoulos A; Alexanian R
    Haematologica; 2005 Jan; 90(1):117-25. PubMed ID: 15642678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic plasmapheresis in treatment of patients with Waldenström's macroglobulinemia.
    Lawson NS; Nosanchuk JS; Oberman HA; Meyers MC
    Transfusion; 1968; 8(3):174-8. PubMed ID: 4968993
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiopulmonary Bypass in the Setting of Waldenström's Macroglobulinemia.
    D'Aloiso BD; Rupchak SS; Gettle KJ; Lima C; Rush RD
    J Extra Corpor Technol; 2018 Jun; 50(2):120-123. PubMed ID: 29921992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of small cell lung cancer with Waldenstrom's macroglobulinemia].
    Nakayama Y; Natsuaki M; Itoh T; Nishioka K
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Jun; 40(6):1021-4. PubMed ID: 1321869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.
    Mullen EC; Wang M
    Clin J Oncol Nurs; 2007 Feb; 11(1):87-95. PubMed ID: 17441400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study.
    Björkholm M; Johansson E; Papamichael D; Celsing F; Matthews J; Lister TA; Rohatiner AZ
    Semin Oncol; 2003 Apr; 30(2):226-30. PubMed ID: 12720141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and management of Waldenstrom's macroglobulinemia.
    Dimopoulos MA; Kyle RA; Anagnostopoulos A; Treon SP
    J Clin Oncol; 2005 Mar; 23(7):1564-77. PubMed ID: 15735132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Waldenström's macroglobulinemia].
    Mongin M
    Sem Hop; 1969 Jun; 45(30):2104-6. PubMed ID: 4309108
    [No Abstract]   [Full Text] [Related]  

  • 34. [Waldenström's macroglobulinemia].
    Brouet JC
    Rev Prat; 1979 Jan; 29(3):317-20, 323-4, 329. PubMed ID: 105399
    [No Abstract]   [Full Text] [Related]  

  • 35. Waldenström's macroglobulinemia.
    McKenna JA
    Clin J Oncol Nurs; 2002; 6(5):283-6. PubMed ID: 12240489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperviscosity syndrome, macroglobulinemia].
    Hatta Y; Sawada U
    Nihon Rinsho; 2004 May; 62 Suppl 5():550-3. PubMed ID: 15197982
    [No Abstract]   [Full Text] [Related]  

  • 37. A review of Waldenstrom's macroglobulinemia.
    McDermott MK; Bell EM
    Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmapheresis in hyperviscosity syndrome.
    Avnstorp C; Nielsen H; Drachmann O; Hippe E
    Acta Med Scand; 1985; 217(1):133-7. PubMed ID: 3919530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines.
    Ansell SM; Kyle RA; Reeder CB; Fonseca R; Mikhael JR; Morice WG; Bergsagel PL; Buadi FK; Colgan JP; Dingli D; Dispenzieri A; Greipp PR; Habermann TM; Hayman SR; Inwards DJ; Johnston PB; Kumar SK; Lacy MQ; Lust JA; Markovic SN; Micallef IN; Nowakowski GS; Porrata LF; Roy V; Russell SJ; Short KE; Stewart AK; Thompson CA; Witzig TE; Zeldenrust SR; Dalton RJ; Rajkumar SV; Gertz MA
    Mayo Clin Proc; 2010 Sep; 85(9):824-33. PubMed ID: 20702770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guideline for diagnosis and treatment of Waldenström's macroglobulinaemia.
    Vos JM; Minnema MC; Wijermans PW; Croockewit S; Chamuleau ME; Pals ST; Klein SK; Delforge M; van Imhoff GW; Kersten MJ; ;
    Neth J Med; 2013 Mar; 71(2):54-62. PubMed ID: 23462052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.